STVN
Stevanato Group·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 2
Ample Liquidity
High Cash/net Profit Ratio
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About STVN
Stevanato Group S.P.A.
The first worldwide producer of insulin cartridges for diabetes treatment
Life Science Tools and Services
--
07/16/2021
New York Stock Exchange
5,521
12-31
Common stock
Via Molinella 17, 35017 Piombino Dese – Padua, Italy
--
Stevanato Group S.p.A. is incorporated under the laws of the Republic of Italy. The company is a leading global provider of drug containment, drug delivery and diagnostic solutions and engineering solutions for the pharmaceutical, biotechnology and life science industries. The company offers an integrated, end-to-end portfolio of products, processes and services that meet customer needs throughout the drug lifecycle, from development to the clinical and commercial stages.
Earnings Call
Q1/2025
Estimate EPS0.1
Actual EPS0.10796
Estimate Revenue280.77M
Actual Revenue277.02M
Navigating Contradictions: Tariff Impacts and Vial Recovery Timelines in 2025's Earnings Call
May 19,2025 11:47
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.12
Actual EPS0.13
Estimate Revenue310.63M
Actual Revenue329.84M
Contradictions in Focus: Analyzing U.S. Onshoring, Vial Market Growth, and Engineering Performance
Aug 06,2025 04:04
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
STVN has released its 2025 Q3 earnings. EPS was reported at 0.16, versus the expected 0.15, beating expectations. The chart below visualizes how STVN has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
STVN has released its 2025 Q3 earnings report, with revenue of 355.77M, reflecting a YoY change of 14.88%, and net profit of 42.32M, showing a YoY change of 26.48%. The Sankey diagram below clearly presents STVN's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
